Logo

Abbott Licenses DNA Probes to Ikonisys

Mar 22, 2005

NEW YORK, March 22 (GenomeWeb News) - Abbott has granted Ikonisys a worldwide license to manufacture and sell DNA probes for its Chromotest, a prenatal diagnostic for chromosomal abnormalities, the companies said today.

 

Ikonisys also obtained from Abbott rights to buy chromosome fluorescence in situ hybridization probes in the fields of pre-implantation genetic diagnosis and automated detection in amniocytes of FISH signals of "the most common chromosomal abnormalities."

Terms of the first agreement call for Ikonisys to pay Abbott an upfront, non-refundable license fee and royalties on commercialized kits. Terms of the second agreement were undisclosed. Ikonisys is based in New Haven, Conn.

Breaking News
The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.